ZYBT vs HCAI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ZYBT

38.4
AI Score
VS
HCAI Wins

HCAI

44.7
AI Score

Investment Advisor Scores

ZYBT

38score
Recommendation
AVOID NEW MONEY

HCAI

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZYBT HCAI Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -40.9% -72.8% ZYBT
Earnings Growth -79.6% -94.1% ZYBT
Tradestie Score 38.4/100 44.7/100 HCAI
Profit Margin -60.0% 0.0% HCAI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD HCAI

Relative Price Performance (Last 90 Days)

ZYBT 1M: +9.5% · 3M: -13.3% HCAI 1M: -69.0% · 3M: -96.5%

Current Technical Phase

ZYBT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.3 · Price: $1.50

HCAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -46.1%), weak momentum, RSI 12

RSI (14): 12.3 · Price: $0.17

Fundamentals Snapshot

Metric ZYBT HCAI
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.4% -0.7%
Gross Margin 0.2% 0.2%
Operating Margin -0.8% 0.0%
EPS -0.22 -48.54
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HCAI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.